Deutsche Stiftung Patientenschutz

Deutsche Stiftung Patientenschutz
Name	Deutsche Stiftung Patientenschutz
Formation	1991
Founder	Renate Krüger
Type	Non-profit organization
Headquarters	Berlin
Location	Germany
Leader title	Chairman
Leader name	Eugen Brysch

Deutsche Stiftung Patientenschutz is a German patient advocacy foundation established to represent the interests of patients in healthcare disputes, policy debates, and media reporting. It engages with institutions across the European Union, German federal bodies, and regional health authorities, while interacting with medical associations, consumer groups, and legal actors. The foundation operates at the intersection of patient rights, medical ethics, and healthcare regulation.

History

The foundation traces origins to reform efforts that followed public debates sparked by cases discussed in the wake of the AIDS crisis, the Thalidomide scandal, and jurisprudence from the Federal Constitutional Court of Germany. Early supporters included figures from the German Red Cross, the Diakonie, and the German Medical Association, and the organization grew amid policy shifts influenced by the European Court of Human Rights, the World Health Organization, and the passage of German statutes such as the Patient Rights Act (Germany). Its development intersected with advocacy trends linked to the Kassenärztliche Bundesvereinigung, the Gemeinsamer Bundesausschuss, and consumer protection groups like Stiftung Warentest. The foundation engaged with legal instruments shaped by decisions in the Bundesverfassungsgericht and administrative practice at the Bundesministerium für Gesundheit, responding to casework involving hospitals like Charité – Universitätsmedizin Berlin, university clinics (e.g., Universitätsklinikum Heidelberg), and private providers including Helios Kliniken.

Mission and Activities

The foundation's mission emphasizes safeguarding patients' rights, promoting transparency in clinical care, and advocating for safe standards comparable to initiatives from the European Patients' Forum, the World Medical Association, and the International Council of Nurses. Activities include providing counseling paralleling services offered by organizations such as German Tenants' Association, publishing reports akin to outputs by the Robert Koch Institute and think tanks like the Wissenschaftszentrum Berlin für Sozialforschung, and litigating or supporting cases with legal partners from chambers like the Deutscher Anwaltverein. It engages in public education through forums similar to those convened by the Deutsche Forschungsgemeinschaft and produces position papers used in deliberations at bodies such as the Bundesinstitut für Arzneimittel und Medizinprodukte and the Paul-Ehrlich-Institut.

Leadership and Organization

Governance has involved leaders drawn from healthcare, law, and civil society, comparable to profiles seen at institutions like the Max-Planck-Gesellschaft, the Fraunhofer-Gesellschaft, and the Stiftung Warentest. Executive and advisory boards include healthcare professionals, lawyers, and ethicists who have faced issues associated with entities such as the Deutsche Krankenhausgesellschaft, the Verband der Ersatzkassen, and academic centers like the Universität Hamburg. Leadership has participated in conferences alongside representatives from the European Commission, the Bundesärztekammer, and the Kassenärztliche Bundesvereinigung, coordinating with patient organizations such as Leukämiehilfe and disease-specific NGOs modeled on Deutsche Krebshilfe.

Campaigns and Advocacy

The foundation has campaigned on matters reminiscent of debates involving the Euthanasia Laws in Europe, regulatory scrutiny of pharmaceuticals overseen by the European Medicines Agency, and transparency issues highlighted by investigative reporting in outlets like Der Spiegel and Die Zeit. Campaign themes include improved patient safety standards pursued alongside initiatives from Transparency International and clinical governance reforms advocated by the Institute for Quality and Efficiency in Health Care (IQWiG). It has mobilized around reimbursement disputes similar to cases in the Statutory Health Insurance system and has submitted evidence in proceedings at the Bundesverfassungsgericht and consultations with the European Parliament.

Funding and Partnerships

Funding sources mirror models used by non-profit actors such as the Robert Bosch Stiftung and include donations, grants, and project funding from foundations similar to the Bertelsmann Stiftung and European programs administered via the European Commission. Partnerships have been formed with legal clinics, university departments like the Charité ethics units, patient associations akin to Deutsche Multiple Sklerose Gesellschaft, and consumer bodies such as Verbraucherzentrale Bundesverband. The foundation has collaborated on research with institutes like the Leibniz Association and participated in cross-border networks affiliated with the European Patients' Academy on Therapeutic Innovation.

Criticism and Controversies

The foundation has faced criticism paralleling scrutiny leveled at advocacy groups like Naked Truth-style exposés, with commentators in Frankfurter Allgemeine Zeitung, Süddeutsche Zeitung, and Die Welt questioning transparency over funding similar to debates around the Karl Lauterbach era health-policy consultancies. Controversies have involved disputes with professional bodies including the Bundesärztekammer and private healthcare companies like Fresenius Medical Care, and have led to legal challenges in administrative courts such as the Bundesverwaltungsgericht. Critics have compared its tactics to those of international NGOs scrutinized by the European Ombudsman and raised issues about the balance between advocacy and stakeholder negotiation reminiscent of debates around the Institut für Qualitätssicherung und Transparenz im Gesundheitswesen.

Category:Health advocacy organizations in Germany